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Background: In animal models, experimentally induced venous congestion causes significant impairment of renal function which is reversible with 
relief of congestion. Similarly, venous congestion can affect the liver causing congestive hepatopathy with biochemical evidence of liver dysfunction 
in the form of elevated international normalized ratio (INR), bilirubin (BIL), and alkaline phosphatase (AP) levels. Given that the liver and kidneys 
share a common venous system, we hypothesized that laboratory evidence of congestive hepatopathy may also indicate congestion-induced renal 
dysfunction. As a result, diuresis of these patients should lead to improvement in renal function (IRF).
Methods: We reviewed consecutive admissions with a primary discharge diagnosis of heart failure, an admission B-type natriuretic peptide (BNP) 
level, and an INR, AP, or BIL level. A BIL or AP level >/=1.5 times the upper limit of normal and an INR >/=1.5 were considered elevated. IRF was 
defined as a >/=20% increase in glomerular filtration rate.
Results: Overall 871 admissions were identified, 798 with an INR and 525 with a BIL or AP level. INR was elevated in 36.1%, BIL in 14.7% and 
AP in 27.6% of admissions. Consistent with a congested state, patients with an elevated marker of congestive hepatopathy were significantly more 
likely to have absence of inferior vena cava inspiratory collapse (OR=3.1, p<0.001) or a BNP in the highest quartile (OR=2.0, p<0.001). IRF was 
significantly more common in patients with an elevated INR, AP, or BIL (OR=2.8, p<0.0001). Patients with an elevation in all three laboratory markers 
had the highest incidence of IRF (OR=3.4, p=0.004). Despite the weak association between BNP and IRF (OR=1.1 per 500 pg/mL, p<0.001), 
restricting the analysis to patients with a BNP above the median further strengthened the association between an elevated marker of congestive 
hepatopathy and IRF (OR=4.6, p<0.001). After controlling for BNP, an elevated INR, BIL, or AP remained a significant predictor of IRF (OR=2.6, 
p<0.0001).
Conclusions: Laboratory evidence of congestive hepatopathy is associated with IRF during diuresis, effects likely mediated via relief of venous 
congestion-induced renal dysfunction.
